Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 21, 2022 at 12:35 pm EST
Share
Bioethics, Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 0.022204 million compared to USD 0.025706 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
For the nine months, net loss was USD 0.072503 million compared to USD 0.083764 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.07 a year ago.
Bioethics, Ltd. is a shell company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company has not commenced any operations nor generated any revenue.
BIOETHICS, LTD. 
